Induction and expression of protective T cells during Mycobacterium avium infections in mice.

Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun (1994) 2.52

Susceptibility of beige mice to Mycobacterium avium: role of neutrophils. Infect Immun (1995) 1.63

T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma. Immunology (1997) 1.50

Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol (1994) 1.47

Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Immunology (1994) 1.25

Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect Immun (1999) 1.16

Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence. Clin Exp Immunol (1995) 1.05

Host response to nontuberculous mycobacterial infections of current clinical importance. Infect Immun (2014) 1.03

The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice. Immunology (1995) 0.88

Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells. Infect Immun (2000) 0.87

Identification of epitopes of fibronectin attachment protein (FAP-A) of Mycobacterium avium which stimulate strong T-cell responses in mice. Infect Immun (1998) 0.80

Processing and presentation of an antigen of Mycobacterium avium require access to an acidified compartment with active proteases. Infect Immun (1996) 0.78

Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis (1979) 16.46

The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol (1987) 6.12

Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun (1970) 5.96

Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J Immunol (1983) 5.22

Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61

Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis (1987) 4.54

Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell (1989) 4.53

Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun (1988) 3.79

Mycobacterium avium complex infection. J Infect Dis (1988) 3.76

Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol (1988) 3.58

Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens. J Exp Med (1985) 2.79

I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol (1985) 2.73

Opportunistic pathogens in the genus Mycobacterium. Annu Rev Microbiol (1985) 2.67

T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect Immun (1989) 2.51

Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor gamma delta. Proc Natl Acad Sci U S A (1991) 2.46

Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). J Immunol (1984) 2.13

Enhancing effect of antilymphocytic serum on mycobacterial infections in mice. Nature (1968) 1.97

The immunology of mycobacterial diseases. Am Rev Respir Dis (1986) 1.96

Expression of the natural resistance gene Lsh in resident liver macrophages. Infect Immun (1984) 1.82

Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG). J Immunol (1983) 1.81

The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. Clin Exp Immunol (1990) 1.78

The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli. Cell Immunol (1970) 1.75

Genetic control of natural resistance to nontuberculous mycobacterial infections in mice. Infect Immun (1986) 1.68

Role of mononuclear phagocytes in expression of resistance and susceptibility to Mycobacterium avium infections in mice. Infect Immun (1986) 1.49

Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene. Immunogenetics (1989) 1.35

Growth of mycobacterium bovis (BCG) in T lymphocyte-depleted mice. Infect Immun (1975) 1.32

Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice. Springer Semin Immunopathol (1988) 1.29

The role of T cell--macrophage interactions in tuberculosis. Springer Semin Immunopathol (1988) 1.29

Killing of Mycobacterium smegmatis by macrophages from genetically susceptible and resistant mice. J Leukoc Biol (1990) 1.22

Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani. Infect Immun (1987) 1.16

Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection. Infect Immun (1988) 1.13

Induction of non-specific immunosuppression in mice by mycobacterial infections and its relationship to macrophage activation. Scand J Immunol (1989) 1.04

T-cell-mediated immunity in persistent Mycobacterium intracellulare infections in mice. Infect Immun (1988) 0.96

Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice. Clin Exp Immunol (1990) 0.93

Mycobacterium lepraemurium infection of nude athymic (nu/nu) mice. Infect Immun (1985) 0.83

The dynamics of infection following BCG and Mycobacterium tuberculosis challenge in T-cell-deficient mice. Tubercle (1987) 0.80

Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun (1994) 2.52

Susceptibility of beige mice to Mycobacterium avium: role of neutrophils. Infect Immun (1995) 1.63

Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Immunology (1994) 1.25

The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes Immun (2011) 0.92

Newborn screening: a national public health programme in Brazil. J Inherit Metab Dis (2007) 0.89

Developments on drug delivery systems for the treatment of mycobacterial infections. Curr Top Med Chem (2008) 0.88

[Follow-up of the first case of Mycobacterium ulcerans infection documented by PCR, genotyping and culture in the Republic of Congo-Brazzaville]. Med Trop (Mars) (2008) 0.86

Differences in resistance of C57BL/6 and C57BL/10 mice to infection by Mycobacterium avium are independent of gamma interferon. Infect Immun (2000) 0.81

Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis. Int J Antimicrob Agents (2007) 0.80

Effects of iron deprivation on Mycobacterium avium growth. Tuber Lung Dis (1999) 0.80

Toxicity of chromated copper arsenate: a study in mice. Environ Res (2010) 0.77

Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection. Antimicrob Agents Chemother (2000) 0.75

Study of vegetative innervation in the oesophagus. I. Perivascular endings. Trab Inst Cajal Invest Biol (1970) 0.75